CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-30 | Ford Alexander President, MGL | Returned to the company | −6,653 | $46.00 | $306K | 120,524 |
| 2018-09-30 | Tobin Bernard President Crescendo BioScience | Returned to the company | −4,958 | $46.00 | $228K | 167,635 |
| 2018-09-30 | Tobin Bernard President Crescendo BioScience | Returned to the company | −6,149 | $46.00 | $283K | 161,486 |
| 2018-09-30 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −5,289 | $46.00 | $243K | 156,946 |
| 2018-09-30 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −6,653 | $46.00 | $306K | 150,293 |
| 2018-09-30 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,361 | $46.00 | $109K | 127,217 |
| 2018-09-30 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,952 | $46.00 | $136K | 124,265 |
| 2018-09-30 | Verratti Mark President Assurex Health Inc. | Returned to the company | −725 | $46.00 | $33K | 85,578 |
| 2018-09-30 | King Gary A. Exec. VP International Ops | Returned to the company | −3,826 | $46.00 | $176K | 137,300 |
| 2018-09-30 | King Gary A. Exec. VP International Ops | Returned to the company | −3,327 | $46.00 | $153K | 133,973 |
| 2018-09-30 | Capone Mark Christopher President & C.E.O. | Returned to the company | −18,295 | $46.00 | $842K | 449,560 |
| 2018-09-30 | Capone Mark Christopher President & C.E.O. | Returned to the company | −8,727 | $46.00 | $401K | 440,833 |
| 2018-09-30 | Sanders Walter Lloyd President Myriad Oncology | Returned to the company | −629 | $46.00 | $29K | 36,824 |
| 2018-09-30 | Sanders Walter Lloyd President Myriad Oncology | Returned to the company | −629 | $46.00 | $29K | 36,195 |
| 2018-09-30 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,544 | $46.00 | $255K | 171,206 |
| 2018-09-30 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,157 | $46.00 | $237K | 166,049 |
| 2018-09-30 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −4,998 | $46.00 | $230K | 149,718 |
| 2018-09-30 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −5,544 | $46.00 | $255K | 144,174 |
| 2018-09-25 | Ford Alexander President, MGL | Returned to the company | −6,653 | $46.65 | $310K | 129,007 |
| 2018-09-25 | Tobin Bernard President Crescendo BioScience | Returned to the company | −4,958 | $46.65 | $231K | 172,593 |
Page 38 of 60 · 1,194 trades